业界动态MHRA

指南:创新许可与获取途径(ILAP)

UK MHRA · 2026-11-09 16:30

摘要

创新许可与获取途径(ILAP)专注于将最具变革性的新药更快速地提供给英国医疗体系中的患者。

English
Guidance: Innovative Licensing and Access Pathway (ILAP)

The Innovative Licensing and Access Pathway (ILAP) is focused on getting the most transformative new medicines to patients in the UK health system more quickly.

内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界